Orchiectomy ProcedureDescription, Latest Information and Doctors
Orchiectomy Overview
Learn About Orchiectomy
Robert Brannigan is a Urologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 34 years. Dr. Brannigan is rated as an Elite provider by MediFind in Orchiectomy. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Low Testosterone, Infertility, Testicular Failure, Vasectomy, and Orchiectomy. Dr. Brannigan is board certified in American Board Of Urology - Urology (Certified).
Penn Urology Cherry Hill
Phillip Pierorazio is a Urologist practicing medicine in Cherry Hill, New Jersey. Dr. Pierorazio is rated as an Elite provider by MediFind in Orchiectomy. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Testicular Cancer, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Orchiectomy. Dr. Pierorazio is board certified in Urology, 2015. Dr. Pierorazio is currently accepting new patients.
Axel Heidenreich practices practicing medicine in Koeln, Germany. Mr. Heidenreich is rated as an Elite expert by MediFind in Orchiectomy. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Prostate Cancer, Teratoma of the Mediastinum, Lymphadenectomy, and Orchiectomy.
Summary: The investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Veterans with mCRPC. In the real-world that is the VHA, the investigators have successfully estimated g values that accurately predict OS and the use of this metric in other settings should now be explored. In the egalitarian system that is the VHA the treatment of prostate cancer is...
Summary: This is a single-arm, multicenter open label, international, phase II study of Bipolar Androgen Therapy (BAT) plus Radium-223 (RAD) in men with metastatic castration-resistant prostate cancer (mCRPC). Men with mCRPC with progressive disease (radiographically and/or biochemically) who have been treated with gonadotropin-releasing hormone (GnRH)-analogue (LHRH agonists/antagonists) continuously or b...

